Kourmouli N, Theodoropoulos PA, Dialynas G, Bakou A, Politou AS, Cowell IG, Singh PB, Georgatos SD. (2000) Dynamic associations of heterochromatin protein 1 with the nuclear envelope. EMBO J.19:6558-6568. [Abstract]
Lanzetti L, Rybin V, Malabarba MG, Christoforidis S, Scita G, Zerial M, Di Fiore PP. (2000) The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5. Nature.408:374-377. [Abstract]
Nielsen E, Christoforidis S, Uttenweiler-Joseph S, Miaczynska M, Dewitte F, Wilm M, Hoflack B, Zerial M. (2000) Rabenosyn-5, a novel Rab5 effector, is complexed with hVPS45 and recruited to endosomes through a FYVE finger domain. J Cell Biol.151:601-612. [Abstract]
Assimakopoulos D, Kolettas E, Zagorianakou N, Evangelou A, Skevas A, Agnantis NJ. (2000) Prognostic significance of p53 in the cancer of the larynx. Anticancer Res.20:3555-3564. [Abstract]
Breit S, Ashman K, Wilting J, Rössler J, Hatzi E, Fotsis T, Schweigerer L. (2000) The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A. Cancer Res.60:4596-4601. [Abstract]
Breit S, Rössler J, Fotsis T, Schweigerer L. (2000) N-myc down-regulates activin A. Biochem Biophys Res Commun.274:405-409. [Abstract]
Christoforidis S, Zerial M. (2000) Purification and identification of novel Rab effectors using affinity chromatography. Methods.20:403-410. [Abstract]
Hatzi E, Breit S, Zoephel A, Ashman K, Tontsch U, Ahorn H, Murphy C, Schweigerer L, Fotsis T. (2000) MYCN oncogene and angiogenesis: down-regulation of endothelial growth inhibitors in human neuroblastoma cells. Purification, structural, and functional characterization. Adv Exp Med Biol.476:239-248. [Abstract]
